|Articles|February 15, 2002
Allergan spin-off places focus on pharmaceuticals New entity formed for optical medical devices
Irvine, CA-Allergan Inc. is separating the pharmaceutical and optical medical device segments of its business in a move aimed at placing the company as the number one player in both arenas.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























